OrbusNeich Sets 2026 AGM to Approve Dividend, Board Mandates and Share Issuance Flexibility

TipRanksApr 13 17:12

ORBUSNEICH: Annual Report 2025

HKEXApr 13 16:30 · Announcements

OrbusNeich Medical Group Holdings Limited (6929) Gets a Buy From CICC

TipRanksMar 16 13:25 · Ratings

CICC: Downgrades target price for Penumbra Medical (06929) to HKD 5.3; overall profitability remains stable.

The company's current direct sales market has expanded to 12, with direct sales revenue expected to account for 58% by 2025. The bank anticipates that this figure will continue to grow in the future.

Zhitong FinanceMar 16 11:19 · Ratings

Allyes Medical (6929.HK): Record-breaking annual performance with core operating profit up 20.2%, demonstrating resilience driven by globalization and innovation.

In 2025, the global medical device industry continues to move forward amid tariff disruptions and geopolitical changes. However, Yep Medical has delivered a robust set of results against the trend: revenue and sales have reached record highs for five consecutive years, core operating profit surged by 20.2% year-on-year, with a full-year dividend of 27 Hong Kong cents, representing a payout ratio of nearly 70%. The market's response was telling: the day after the earnings release, the company’s share price opened higher and continued to rise, closing with a cumulative increase of 6.11%. Such performance is uncommon in the current climate of uncertainty within the global healthcare sector. With over two decades of experience building a global foundation and continuously upgrading its product portfolio, Yep Medical once again demonstrated its resilience.

Gelonghui FinanceMar 16 08:50

Alchip Technologies (06929.HK): Robust performance in 2025, acceleration in 2H25, and enhanced shareholder returns

The company's 2025 performance is largely in line with market expectations. The full-year results for 2025 were announced as follows: revenue of US$180 million, representing a year-on-year increase of 10.0%; net profit attributable to shareholders amounted to US$41.9 million, marking a year-on-year increase of 5.5%, primarily driven by interest.

CICCMar 15 14:37